A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation

A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation

Abstract Background Compound kushen injection (CKI), a Chinese patent drug, is widely used in the treatment of various cancers, especially neoplasms of the digestive system. However, the underlying mechanism of CKI in pancreatic cancer (PC) treatment has not been totally elucidated. Methods Here, to...

Full description

Saved in:
Bibliographic Details
Main Authors: Chao Wu, Zhi-Hong Huang, Zi-Qi Meng, Xiao-Tian Fan, Shan Lu, Ying-Ying Tan, Lei-Ming You, Jia-Qi Huang, Antony Stalin, Pei-Zhi Ye, Zhi-Shan Wu, Jing-Yuan Zhang, Xin-Kui Liu, Wei Zhou, Xiao-Meng Zhang, Jia-Rui Wu
Format: article
Language:EN
Published: BMC 2021
Subjects:
Compound kushen injection
Pancreatic cancer
WGCNA
Network pharmacology
Other systems of medicine
RZ201-999
Online Access:https://doaj.org/article/c79b92292800401c87710b1a1ba61dfa
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/c79b92292800401c87710b1a1ba61dfa

Similar Items